JoEllen Zembruski-Ruple, while in the care of New York City’s renowned Memorial Sloan Kettering Cancer Center, swallowed the first three chemotherapy pills to treat her squamous cell carcinoma on Jan.
Overexpression of epidermal growth factor receptor (EGFR) has been associated with aggressive tumor phenotypes, chemotherapy, and radiation resistance, as well as poor survival in preclinical and ...
Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study Options for single-agent ...
During the past few years, six clinical trials have been published on the treatment of advanced or metastatic gastric and gastroesophageal cancer using the combination capecitabine and irinotecan. [54 ...
March 1, 2012 — The anti-inflammatory drug celecoxib (Celebrex, Pfizer) can be used to significantly reduce hand-foot syndrome (HFS), the most common adverse effect of an increasingly popular ...
(RTTNews) - Processa Pharmaceuticals, Inc. (PCSA) reported preliminary Phase 2 data showing that its lead oncology candidate, NGC-Cap, a combination of PCS6422 and capecitabine, significantly ...
The FDA added a boxed warning to capecitabine and 5-FU labels, noting the risk of serious adverse reactions or death in patients with complete DPD deficiency. Capecitabine and 5-FU are both nucleoside ...
“Using Panitumumab with metronomic Capecitabine is considered an accepted maintenance regimen in wild type Ras metastatic colorectal cancer regardless of the primary site” In this study, researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results